SOROS FUND MANAGEMENT LLC

Q4 2022 13F-HR Holdings

Location
New York, NY
Holdings as of
12/31/2022
Date filed
2/13/2023
Form type
13F-HR
Num holdings
208
Total value ($000)
$7,260,545
Net value change ($000)
+1,404,063 (24.0%)
New positions
27
Sold out positions
73
Turnover %
82.4%
Sector allocation + QoQ delta (equities-only)

Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown

Snapshot: Change Analysis

Compared to Q3 2022
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
Horizon Therapeutics Public Ltd Co 325,297 NEW
LQD 254,951 NEW
FHN 209,132 NEW
Altra Industrial Motion Corp. 119,500 NEW
Signify Health, Inc. 80,978 NEW
GOOGL 58,049 59.9%
FEZ 53,201 NEW
SPY 45,961 NEW
MTN 28,602 NEW
EL 27,912 NEW
Top Reduces (Value $000, Stocks/ETFs)
Biohaven Pharmaceutical Holding Co Ltd. -343,539 -100.0%
DUKE REALTY CORP -307,832 -100.0%
RIVN -274,033 -50.9%
ALLEGHANY CORP /DE -169,520 -100.0%
AMZN -148,147 -66.2%
DHI -114,503 -65.0%
ChemoCentryx, Inc. -81,365 -100.0%
SIERRA WIRELESS INC -42,610 -100.0%
TMUS -34,644 -83.9%
NKE -26,227 -77.9%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 1,373,214 (18.9% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type